CAS: 16846-24-5; (2S,3S,4R,6S)-6-(((2R,3S,4R,5R,6S)-6-(((4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-Acetoxy-10-Hydroxy-5-Methoxy-9,16-Dimethyl-2-Oxo-7-(2-Oxoethyl)Oxacyclohexadeca-11,13-Dien-6-yl)Oxy)-4-(Dimethylamino)-5-Hydroxy-2-Methyltetrahydro-2H-Pyran-3-yl)Oxy)-4-Hydroxy-2,4-

该化合物是一种主要来自细菌链球菌的发酵的大型硫化抗生素,主要来自此细菌的发酵,其特点是它能够抑制细菌蛋白合成,使其与50-S的脊髓膜炎亚元素结合,从而防止易感染细菌的生长.乔萨米辛展示了多种防止各种克格菌阳性细菌和某些克格阴性生物的活动,使其有效地治疗呼吸道感染,皮肤感染和某些性传染疾病.该化合物通常通过口述方式施用,以其有利的药用植物基因特性为人所知,包括良好的组织渗透和相对较长的半衰期.乔萨米辛还因其低毒性特征而引人注目,有助于其治疗用途.然而,与其他抗生素一样,它也可以导致抗生素抗体受滥用而发展.其化学结构包括一个大型的乳腺环,这是微生物的常见特征,也是微生物抗生素,有助于其生物活动和稳定性.

结构式图片

上下游产品

乙酰吉他霉素 Kitasamycin 16846-34-7
2',9-O-Diacetyl Josamycin 22875-07-6

合成工艺路线路线简述

    2',9-O-Diacetyl Josamycin 反应生成交沙霉素
    参考文献:Oka,Jsixiko;Osono,Takasi;Nagaki,Xideho;Miesi,Tosiaki;Abeh,Sedzo;Sajt+
    标题:Oka,Jsixiko;Osono,Takasi;Nagaki,Xideho;Miesi,Tosiaki;Abeh,Sedzo;Sajt+

    海关参考信息

    专利信息


    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:US-2023399688-A1
    优先权日:2015-08-20
    标 题 :Compositions and multiplexed systems for coupled cell-free transcription-translation and protein synthesis and methods for using them
    发明人:CULLER STEPHANIE; CHEN IHSIUNG BRANDON; PHARKYA PRITI; VAN DIEN STEVE; BARTON NELSON
    权利人:GENOMATICA INC
    摘要:In alternative embodiments, provided herein are transcription/translation (TX-TL) systems and methods of using them for use as rapid prototyping platforms for the synthesis, modification and identification of natural products (NPs), and natural product analogs (NPAs) and secondary metabolites, from biosynthetic gene cluster pipelines. In alternative embodiments, exemplary TX-TL systems as provided herein are used for the combinatorial biosynthesis of natural products (NPs), natural product analogs (NPAs) and secondary metabolites. In alternative embodiments, exemplary TX-TL systems as provided herein are used for the rapid prototyping of complex biosynthetic pathways as a way to rapidly assess combinatorial and biosynthetic designs before moving to cellular hosts. In alternative embodiments, these exemplary TX-TL systems are multiplexed for high-throughput (HT) automation and for prototyping engineered platforms for the synthesis or modification of natural products (NPs), and natural product analogs (NPAs) and secondary metabolites analogs.

    专利号:US-10472663-B2
    优先权日:2015-01-21
    标 题:Procedure for the rapid determination of bacterial susceptibility to antibiotics that inhibit protein synthesis
    发明人:FERNÃ?NDEZ GARCÃ?A JOSÉ LUIS; GOSÃ?LVEZ BERENGUER JAIME; BOU ARÉVALO GERMÃ?N; TAMAYO NOVAS MARIA; SANTISO BRANDARIZ REBECA; OTERO FARIÑA FÃ?TIMA MARÃ?A
    权利人:ABM TECH LLC
    摘要:The present invention relates to a method for the rapid evaluation of bacterial susceptibility or non-susceptibility of bacteria to antibiotics that inhibit protein synthesis. The rationale is to identify bacterial responses that depend or are influenced by protein synthesis. If this response is prevented or reduced by the antibiotic that inhibits the protein synthesis, the bacteria are susceptible to this antibiotic. Otherwise, if the response keeps similar despite the incubation with the antibiotic, the bacteria are not susceptible or resistant to this antibiotic. These responses could be determined at the DNA lev-el, cell wall level, morphological level or any other experimental approach, including metabolic, bio-chemical, physiological or genetic processes.

    专利号:WO-2009056955-A1
    优先权日:2007-10-30
    标题 :Amine-bearing phospholipids (abps), their synthesis and use
    发明人:ZUMBUEHL ANDREAS
    权利人:UNIV BASEL; ZUMBUEHL ANDREAS
    摘要:Disclosed herein are amine-bearing phospholipids (ABP). The ABPs display many properties and functionalities of naturally occurring phospholipids, but also new properties and functionalities, such as the ability to polymerize while maintaining structural integrity, that may supplement or expand the functionalities of naturally occurring phospholipids.

    专利号:US-9868747-B2
    优先权日:2014-02-18
    标题:Marinopyrrole derivatives and methods of making and using same
    发明人:LI RONGSHI; SEBTI SAID; LIU YAN; QIN YONG; SONG HAO; CHENG CHUNWEI
    权利人:H LEE MOFFITT CANCER CT & RES; CHONGQING ZEIN PHARMACEUTICAL CO LTD
    摘要:Marinopyrrole derivatives and methods for their synthesis and use are described herein. Novel cyclic and symmetric marinopyrroles with triazole substituents having antibacterial activity against resistant bacterial strains, such as MRSA are introduced. Also provided are methods of using the compounds for treating or preventing cancer and/or microbial infections.

    专利号:US-8143035-B2
    优先权日:2006-09-22
    标题 :Pantothenate kinase overexpression and pantothenic acid supplementation in actinomycetes
    发明人:LEE HEI CHAN; SOHNG JAE KYUNG; SAN KA-YIU
    权利人:LEE HEI CHAN; SOHNG JAE KYUNG; SAN KA-YIU; RICE UNIVERSITY
    摘要:The invention relates to the synthesis of polyketides in Actinomycetes by overexpression of pantothenate kinase and supplementation with pantothenic acid. This results in increasing in vivo CoA production and thereby drives increased production of secondary metabolites, such as polyketides.
    博瑞生物医药(苏州)股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bright-gene.com
    电话: 0512-0512-62551764 18013103761👤
    📞博瑞生物医药(苏州)股份有限公司 ⚠️参考联系方式

    销售电话:0512-0512-62551764 18013103761
    邮箱:sales01@bright-gene.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Matsui K, Muranaka M, Yamaguchi T, Maeda M. Combination Therapy with Betamethasone and Josamycin Demonstrates Superior Therapeutic Efficacy in an NC/Nga Mouse Model of Atopic Dermatitis. Biol Pharm Bull. 2023;46(5):693-699. doi: 10.1248/bpb.b22-00781. 44(6):798-803. doi: 10.1248/bpb.b20-00976.
    192:113679. doi: 10.1016/j.jpba.2020.113679. Epub 2020 Oct 13. 36(9):1302-1313. doi: 10.1080/19440049.2019.1628357. Epub 2019 Jun 26. 33(12):1058-1066. doi: 10.1002/rcm.8439.
    105:498-505. doi: 10.1016/j.biopha.2018.05.139. Epub 2018 Jun 5.

    合成参考文献


    摘要:S6 | ITNANTIBIOTIC | Antibiotic List from the ITN MSCA ANSWER | DOI:10.5281/zenodo.2621956
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知